요관경 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of ureteroscope Market

The global ureteroscope market has been witnessing steady expansion, driven by the rising prevalence of urinary stone disease and increasing adoption of minimally invasive urological procedures. According to Fortune Business Insights, the market was valued at USD 1.34 billion in 2025 and is projected to grow to USD 1.42 billion in 2026. By 2034, the global ureteroscope market is forecast to reach USD 2.24 billion, registering a compound annual growth rate (CAGR) of 5.91% during the forecast period (2026-2034).

In 2025, North America dominated the global market with a share of 36.03%, supported by advanced healthcare infrastructure and high procedural volumes.

Market Drivers

Rising Prevalence of Urolithiasis

The increasing incidence of urolithiasis is a primary factor driving ureteroscope demand worldwide. Globally, urinary stone disease affects nearly 15% of the population, with lifestyle changes, dietary habits, global warming, alcohol consumption, and metabolic disorders contributing to disease growth. In the United States alone, kidney stones affect approximately 9% of the population, resulting in a rising number of ureteroscopic procedures. As a result, demand for advanced ureteroscopes continues to grow steadily from 2025 onward.

Technological Advancements

Technological innovation plays a vital role in market expansion. The shift from conventional rigid devices to flexible and digital ureteroscopes has improved visualization, maneuverability, and procedural success rates. Digital imaging, enhanced optics, and improved durability have strengthened the adoption of flexible ureteroscopy for stone removal and diagnostic procedures, particularly during the 2026-2034 forecast period.

Market Restraints

Despite strong growth potential, the market faces challenges. High costs of digital and single-use ureteroscopes, combined with limited reimbursement in developing regions, restrict adoption. Additionally, ureteroscopy requires highly skilled professionals, and shortages of trained urologists in economically weaker regions may hamper market expansion during the forecast period.

Market Segmentation Analysis

By Product Type

Based on product type, the market is segmented into flexible, semi-flexible, and rigid ureteroscopes. The flexible ureteroscope segment held the largest market share, accounting for 57.19% in 2026, due to higher procedural success rates and increasing preference for minimally invasive interventions. Continuous innovations in fiber-optic and digital flexible ureteroscopes are expected to reduce the utilization of rigid devices in the coming years.

By Application

By application, the market is categorized into urolithiasis, urothelial cancer, and others. The urolithiasis segment dominated the market, contributing 74.79% of global revenue in 2026, reflecting the growing burden of urinary stones and the effectiveness of ureteroscopy compared to alternative treatment methods.

By End User

In terms of end users, the market includes hospitals, specialty clinics, and others. The hospital segment led the market, accounting for 55.74% in 2026, due to better infrastructure, availability of skilled healthcare professionals, and favorable reimbursement policies.

Regional Insights

North America recorded a market size of USD 0.48 billion in 2025, driven by high procedure volumes and affordability of advanced ureteroscopes.

Europe held the second-largest share, supported by a growing geriatric population and increasing product approvals.

The Asia Pacific region is expected to grow at a faster pace during the forecast period due to rising healthcare expenditure and expanding presence of key manufacturers in China, India, and Japan. By 2026, Japan, China, and India are projected to reach USD 0.07 billion, USD 0.09 billion, and USD 0.03 billion, respectively.

Competitive Landscape

The ureteroscope market is moderately consolidated, with key players such as Olympus Corporation, Boston Scientific Corporation, Stryker, KARL STORZ, and Richard Wolf GmbH. Major companies focus on product innovation, single-use devices, and expansion in emerging markets to strengthen their global presence.

Conclusion

In conclusion, the global ureteroscope market is poised for sustained growth from USD 1.34 billion in 2025 to USD 2.24 billion by 2034, driven by the rising prevalence of urolithiasis, technological advancements, and increasing adoption of minimally invasive urological procedures. While high device costs and limited skilled workforce remain challenges, continuous innovation and expanding healthcare infrastructure-especially in Asia Pacific-are expected to support long-term market growth during the forecast period.

Segmentation

By Product

• Flexible
• Semi-flexible
• Rigid

By Application

• Urolithiasis
• Urolithial Cancer
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

By Geography

• North America (USA, Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia, Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of South America)
• Middle East & Africa (South Africa, GCC Countries, Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Urolithiasis, By Country/Region
• 4.2. Technological Advancements in Ureteroscope
• 4.3. Recent Industry Developments (Mergers, Partnerships, and Acquisitions)
• 4.4. Impact of COVID-19 on Ureteroscope Market

5. Global Ureteroscope Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Flexible
  • 5.2.2. Semi-flexible
  • 5.2.3. Rigid
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Urolithiasis
  • 5.3.2. Urolithial Cancer
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Specialty Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Ureteroscope Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product
  • 6.2.1. Flexible
  • 6.2.2. Semi-flexible
  • 6.2.3. Rigid
• 6.3. Market Analysis - By Application
  • 6.3.1. Urolithiasis
  • 6.3.2. Urolithial Cancer
  • 6.3.3. Others
• 6.4. Market Analysis - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Specialty Clinics
  • 6.4.3. Others
• 6.5. Market Analysis - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Ureteroscope Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product
  • 7.2.1. Flexible
  • 7.2.2. Semi-flexible
  • 7.2.3. Rigid
• 7.3. Market Analysis - By Application
  • 7.3.1. Urolithiasis
  • 7.3.2. Urolithial Cancer
  • 7.3.3. Others
• 7.4. Market Analysis - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. Market Analysis - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Ureteroscope Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product
  • 8.2.1. Flexible
  • 8.2.2. Semi-flexible
  • 8.2.3. Rigid
• 8.3. Market Analysis - By Application
  • 8.3.1. Urolithiasis
  • 8.3.2. Urolithial Cancer
  • 8.3.3. Others
• 8.4. Market Analysis - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Specialty Clinics
  • 8.4.3. Others
• 8.5. Market Analysis - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Ureteroscope Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product
  • 9.2.1. Flexible
  • 9.2.2. Semi-flexible
  • 9.2.3. Rigid
• 9.3. Market Analysis - By Application
  • 9.3.1. Urolithiasis
  • 9.3.2. Urolithial Cancer
  • 9.3.3. Others
• 9.4. Market Analysis - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others
• 9.5. Market Analysis - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Ureteroscope Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product
  • 10.2.1. Flexible
  • 10.2.2. Semi-flexible
  • 10.2.3. Rigid
• 10.3. Market Analysis - By Application
  • 10.3.1. Urolithiasis
  • 10.3.2. Urolithial Cancer
  • 10.3.3. Others
• 10.4. Market Analysis - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Specialty Clinics
  • 10.4.3. Others
• 10.5. Market Analysis - By Country/Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, Strategies, Financials (based on availability))
  • 11.5.1. Stryker
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & Services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. Strategies,
    • 11.5.1.6. Financials (based on availability)
  • 11.5.2. Olympus Corporation
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & Services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. Strategies,
    • 11.5.2.6. Financials (based on availability)
  • 11.5.3. Richard Wolf GmbH.
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & Services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. Strategies,
    • 11.5.3.6. Financials (based on availability)
  • 11.5.4. KARL STORZ
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & Services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. Strategies,
    • 11.5.4.6. Financials (based on availability)
  • 11.5.5. PENTAX Medical
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & Services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. Strategies,
    • 11.5.5.6. Financials (based on availability)
  • 11.5.6. Elmed Electronics & Medical Industry & Trade Inc.
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & Services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. Strategies,
    • 11.5.6.6. Financials (based on availability)
  • 11.5.7. AED.MD
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & Services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. Strategies,
    • 11.5.7.6. Financials (based on availability)
  • 11.5.8. Other Players
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & Services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. Strategies,
    • 11.5.8.6. Financials (based on availability)

12. Strategic Recommendations